GASTROENTEROLOGY:

Currently IBI is represented on the market of gastroenterology by products for the therapy of abdominal pathology, acid hypersecretion and dyspepsia, for liver pathologies such as cholelits, colelithiasis, colesthasis and other chronic liver diseases such as steatosis and steatohepatitis, and by products for the improvement of peristalsis, meteorism and spastic states of the smooth muscles to cure secondary gastro-intestinal symptoms. view products >

ANTIBIOTICS:

Ibi has been involved in the production of pharmaceutically active raw materials and of ethical specialties in the field of antibiotic therapy for many years. Ibi is particularly specialized in the production of injectable sterile penicillins that are exported throughout the world. Ibi’s line of antibiotics includes numerous products belonging to the classes of cephalosporins, of quinolones, of aminoglycosides and of lincosamides. These sectors are a tradition for Ibi and make up the company’s core-business. The highest levels of quality are required for antibiotic therapy and a careful choice of the product to administer is necessary in order to avoid bacterial resistance, still an issue that is the subject of constant research. The high quality of its products, confirmed by certification by the most important health authorities in the world: FDA (Food and Drug Administration), TGA (Therapeutic Good Administration), MCA (Medicine Control Agency) - has allowed Ibi to become the privileged partner of important international organizations. The discovery and evolution of antibiotics represent a valuable medical, scientific contribution to the well-being of mankind. Antibiotics must always be prescribed and their use monitored by one’s doctor who should evaluate their real usefulness and which drug to choose by the diagnostic and monitoring means he has at hand. view products >

INFLAMMATION AND PAIN:

Ibi produces different medicines for pain therapy and the treatment of inflamatory states that have been widely tested in recent years for efficacy and speed of action, offering a wide range of formulations to satisfy the needs of doctors and patients. In addition Ibi has a well known product for the treatment of the capillary fragility associated with edema and minor trauma that has been the subject of numerous clinical efficacy studies for the last 30 years especially in post-operative therapy (Edeven). view products >

PNEUMOLOGY:

Among diseases of the respiratory system, chronic obstructive pulmonary disease (COPD) on the rise due to increased life expectancy and an unhealthy life style. Ibi’s medicines releave the patient’s symptoms and allow him/her to recover autonomy. The adoption of a healthier life style and regular physical exercise are more effective than medicine in preserving lung efficiency. view products >